Effects of Omeprazole on Plasma Levels of Raltegravir
Open Access
- 15 February 2009
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 48 (4) , 489-492
- https://doi.org/10.1086/596503
Abstract
Raltegravir, a human immunodeficiency virus type 1 (HIV-1) integrase inhibitor, has pH-dependent solubility. Raltegravir plasma concentration increasKeywords
This publication has 7 references indexed in Scilit:
- Raltegravir with Optimized Background Therapy for Resistant HIV-1 InfectionNew England Journal of Medicine, 2008
- Lack of a Pharmacokinetic Effect of Raltegravir on Midazolam: In Vitro/In Vivo CorrelationThe Journal of Clinical Pharmacology, 2008
- Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid–liquid extraction and HPLC-MS/MSJournal of Chromatography B, 2007
- Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trialThe Lancet, 2007
- Pharmacokinetic Drug Interaction Profiles of Proton Pump InhibitorsDrug Safety, 2006
- Gastric Secretory Failure in Patients with the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1988
- Gastropathy and Ketoconazole Malabsorption in the Acquired Immunodeficiency Syndrome (AIDS)Annals of Internal Medicine, 1988